Medicare Enrolled

Dr. Martin Prince, MD, PHD, FACR

Radiation Oncology · New York, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Mixed engagement
416 E 55TH ST, New York, NY 10022
2127466801
In practice since 2006 (20 years)
NPI: 1356373096 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Prince from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Prince? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Prince

Dr. Martin Prince is a radiation oncology specialist in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Prince performed 2,768 Medicare services across 146 unique beneficiaries.

Between the years covered by Open Payments, Dr. Prince received a total of $283,892 from 5 pharmaceutical and/or device companies across 25 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Prince is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 46% volume in NY $283,892 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,768
Medicare services
Top 46% in NY for radiation oncology
146
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~138 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
MRI contrast dye injection (gadobutrol) 2,398 $0 $10
Gadobenate dimeglumine injection
Administration of gadobenate dimeglumine, a contrast agent used to enhance imaging results.
 260 $1 $9
MRI of abdomen without contrast
An MRI scan of the abdomen that uses magnetic fields and radio waves to create detailed images of internal organs and tissues without the use of contrast dye.
 69 $162 $3,033
MRI of abdomen with and without contrast
An MRI scan of the abdomen using contrast dye before and after administration to create detailed images of internal structures.
 24 $321 $3,652
MRI of pelvis with and without contrast
A magnetic resonance imaging scan of the pelvic area performed both before and after the administration of a contrast dye to enhance image detail.
 17 $227 $4,168
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$283,892
Total received (2018-2024)
Avg $94,631/year across 3 years
Top 2% in NY for radiation oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
5
Companies
25
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$273,933 (96.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,691 (3.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$268 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$90
2019
$9,759
2018
$274,043

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GE HEALTHCARE
$90
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
BRACCO DIAGNOSTICS INC.
$238,733
Liebel-Flarsheim LLC
$35,200
Otsuka America Pharmaceutical, Inc.
$9,691
GE HEALTHCARE
$158
Bayer HealthCare Pharmaceuticals Inc.
$110
Top 3 companies account for 99.9% of all-time payments
Associated products mentioned in payments ›
Eovist · Gadavist · Isovue · JYNARQUE · MULTIHANCE · Multihance · OptiStar Elite · SAMSCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 2% for radiation oncology in NY.

Looking for a radiation oncology specialist in New York?
Compare radiation oncologists in the New York area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologists nearby

Geographic Context

Radiation oncologists within 10 mi
2,048
Per 100K population
125.8
County median income
$104,553
Nearest hospital
NEW YORK-PRESBYTERIAN HOSPITAL
0.5 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Prince is a mixed practice specialist, with moderate Medicare volume, with mixed engagement industry engagement in the top 2% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Prince experienced with mri contrast dye injection (gadobutrol)?
Based on Medicare claims data, Dr. Prince performed 2,398 mri contrast dye injection (gadobutrol) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Prince receive payments from pharmaceutical companies?
Yes. Dr. Prince received a total of $283,892 from 5 companies across 25 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Prince's costs compare to other radiation oncologists in New York?
Dr. Prince's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Prince) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Radiation Oncologists in New York
Browse radiation oncologists in New York ranked by procedure volume and transparency data.
Highest volume
Top Radiation Oncologists in NY
Radiation oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Radiation Oncologists in NY
Which NY radiation oncologists receive the most from drug and device companies.
By company
BRACCO DIAGNOSTICS INC. Payments to Doctors
See all physicians who received payments from BRACCO DIAGNOSTICS INC.
By company
Liebel-Flarsheim LLC Payments to Doctors
See all physicians who received payments from Liebel-Flarsheim LLC.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →